Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlor-Trimeton Effects on Voice Function
NCT05858216Phase 1Completed
- Sponsor
- Auburn University
- Start
- Jun 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of chlorpheniramine in allergic rhinitis (AR), sponsored by Auburn University. Primary endpoints: Urine specific gravity, Fundamental frequency and 7 more. Started Jun 2023; status: completed.
02
Drugs
chlorpheniramine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT05858216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05858216.